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http:WHAT THIS PAPER ADDS
This study is the ﬁrst to include a large sample of patients presenting exclusively with chronic mesenteric
ischemia, with a median follow up longer than 5 years. This department has great experience in the ﬁeld of
chronic mesenteric ischemia, and care was always taken to get the optimal follow up for this speciﬁc population.
Here the experience is reported and the actual long-term good results for open surgery in the modern era are
demonstrated.Objectives: Both open surgery (OS) and endovascular surgery (ES) have been proposed for the treatment of
symptomatic chronic mesenteric ischaemia (CMI). OS was considered the gold standard but ES is increasingly
proposed as the ﬁrst option. The aim was to report long-term outcomes associated with OS in patients suffering
CMI in the modern era in order to help in choose between the two techniques.
Materials and methods: A retrospective single centre analysis of all consecutive digestive artery
revascularizations performed for CMI between January 2003 and December 2012 was carried out. Primary
outcomes were 30 day mortality and morbidity, and secondary outcomes were survival, primary patency (PP),
secondary patency (SP), and freedom from digestive symptoms, depending on the completeness of the
revascularization performed.
Results: Eighty-six revascularizations were performed. Median follow up was 6.9 years (range 0.3e20.0). The 30
day mortality and morbidity rates were respectively 3.5% and 13.9%. Ten year survival was 88% for complete
revascularization (CR) and 76% for incomplete revascularization (IR) (p ¼ .54). The PP was 84% at 10 years for CR
and 87% respectively for IR (p ¼ .51). The 10 year SP was 92% for CR and 93% for IR (p ¼ .63). Freedom from
digestive symptoms was inﬂuenced by the completeness of revascularization: 79% for CR versus 65% for IR at 10
years (p ¼ .04).
Conclusions: OS for CMI, especially complete revascularization, provides lasting results despite high morbidity.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Article history: Received 14 July 2014, Accepted 11 January 2015, Available online 26 February 2015
Keywords: Chronic mesenteric ischaemia, Open surgery, Mesenteric vascular diseaseINTRODUCTION
Chronic mesenteric ischaemia (CMI) secondary to arterial
insufﬁciency was ﬁrst recognized and described by Chienne1
in 1869, followed by Councilman2 in 1894 with the anatom-
ical description of the celiac trunk (CT) and superior mesen-
teric artery (SMA) occlusions. The recognition of abdominal
angina as a vascular disease representing a precursor to fatal
intestinal vascular occlusion was made by Dunphy in 1936.3
In 1957 Mikkelson4 was the ﬁrst to propose a surgical treat-
ment for occlusive lesions of the SMA. One year later, Shawrresponding author. A. Lejay, Department of Vascular Surgery and
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//dx.doi.org/10.1016/j.ejvs.2015.01.004and Maynard5 described the ﬁrst surgical thromboendar-
terectomy of the SMA proving its effectiveness in relieving
the symptoms associated with CMI. However, the clinical
manifestations of CMI can remain poor owing to the exten-
sive collateral development of digestive arteries, but if in-
testinal blood ﬂow is unable to supply physiological
gastrointestinal demands, mesenteric ischemia will occur. If
preventive treatment in asymptomatic patients is contro-
versial, treatment of symptomatic CMI is widely accepted in
order to prevent acute mesenteric ischemia (AMI), which
may cause bowel infarction and death. Open surgery (OS)
techniques and options are endarterectomy, re-implantation,
and aorto-mesenteric and/or celiac bypass grafting. OS is
effective but associated with relatively high peri-operative
mortality and morbidity rates, ranging from 1% to 17% for
mortality, and from 2% to 33% for morbidity.6e8 If OS
mesenteric revascularization has been the primary method
of treatment for CMI, endovascular surgery (ES) has rapidly
588 A. Lejay et al.risen as a valuable option and is now being used more often
than surgery in the United States.9 Comparisons between OS
revascularizations and ES for visceral arterial occlusive dis-
ease have been published, but large series studying long-
term outcomes associated with OS revascularization are
still missing. The purpose of this report was to review the 20
year experience from a single institution of OS treatment of
patients with CMI, depending on the completeness of the
revascularization.MATERIALS AND METHODS
A retrospective analysis of all consecutive patients operated
on for digestive revascularization for CMI between January
1993 and December 2012 was performed. Inclusion criteria
were patients presenting at least two of the following
digestive symptoms: typical chronic postprandial abdominal
pain, weight loss, a fear of food (because of pain), meals
split into smaller portions (food fear with meal splitting),
digestive troubles (diarrhoea, nausea, or vomiting), and the
presence of a signiﬁcant diameter stenosis of at least 70% in
one or more digestive artery, CT, SMA, or inferior mesen-
teric artery (IMA) on duplex scan examination, conﬁrmed by
pre-operative radiological imaging: arteriography or
computed tomography angiography.
Exclusion criteria were incidental digestive artery stenosis
without symptoms, treatment of any digestive artery in
combination with another aortic procedure without CMI
symptoms, and AMI.
During this period, the policy of the team concerning CMI
was always the same: OS was carried out, except in patients
that were considered too high risk. In fact, surgical risk was
always deﬁned pre-operatively according to the guidelines
for the peri-operative cardiac management in non-cardiac
surgery of the European Society of Anaesthesiology. High
risk patients were thus deﬁned as patients with three or
more serious comorbidities, including chronic obstructive
pulmonary disease (forced expiratory volume in 1 second
[FEV1] < 80% theoretical value), congestive heart failure
(left ventricular ejection fraction [LVEF] < 40%), coronary
artery occlusive disease (deﬁned as history of any revas-
cularization of the coronary arteries), or chronic renal
insufﬁciency (glomerular ﬁltration rate [GFR] < 30 mL/min/
1.73 m2). In these patients where general anaesthesia was
mostly contraindicated, endovascular surgery was pro-
posed. For all other patients, OS was proposed, and the
policy was to provide anterograde revascularization in all
cases, when possible. Retrograde revascularizations were
only carried out in cases of heavy calciﬁcation of the celiac
aorta where clamping was impossible.
The following pre-operative parameters were recorded:
demographic data, cardiovascular risk factors (diabetes,
hypertension, dyslipidaemia, tobacco use), comorbidities (a
history of myocardial infarction, coronary bypass, or stent-
ing corresponding to cardiac comorbidity, a creatinine
clearance less than 30 mL/min for renal comorbidity, and a
history of stroke or previous carotid endarterectomy for
cerebral comorbidity), and blood albumin level.An angiographic score was assigned, regardless of pre-
operative angiography imaging, to evaluate the digestive
arterial system in each patient: for each digestive artery (CT,
SMA, IMA), occlusion was rated 0, a stenosis greater than
70% was rated 1, a stenosis between 50% and 70% was
rated 2, a stenosis of less than 50% was rated 3, and a
normal artery was rated 4. This score was developed in
order to have an objective and easily quantiﬁed value for
each patient.
Surgical procedures performed were listed, including the
type of revascularization done: complete or incomplete.
Thirty day mortality and morbidity were recorded.
Morbidity was deﬁned as surgery related morbidity (graft
thrombosis, haemorrhagic complication, operative site
infection) or systemic morbidity (renal, pulmonary, cardiac,
or neurologic failures).
Patients were reviewed in the outpatient clinic at 30 days
and at 6 months, and annually thereafter. Ultrasound
monitoring was performed in each case, and a CT scan when
ultrasound examination was non-contributory. Survival,
primary patency, secondary patency, and freedom from
digestive symptoms were analysed according to the
completeness of the revascularization.
Statistical analysis was performed using GraphPad Prism
under the supervision of the University Statistics Depart-
ment. Non-normally distributed data are presented as me-
dian (MED) and interquartile range (IQR). KaplaneMeier
analysis and log-rank test were used to compare survival,
primary patency, secondary patency, and freedom from
digestive symptoms rates. The chosen signiﬁcance level was
5% (p < .05).
RESULTS
Population
Eighty-six patients, 52 men and 34 women (sex ratio 1.53),
with median age 62 (IQR 56e75) years were included.
During the same period 31 revascularizations considered as
preventive (completed for asymptomatic patients present-
ing at least 2 lesions regardless of the Mikkelsen rule, or
completed during aortobifemoral bypasses done for occlu-
sive disease), 39 endovascular procedures performed in
patients with poor clinical status, and 36 procedures per-
formed for AMI were excluded.
Median follow up was 6.9 (range 0.3e20.0) years. No
patients dropped out the study. Cardiovascular risk factors
were diabetes mellitus in 22 patients (26%), hypertension in
72 patients (84%), dyslipidaemia in 48 patients (56%), and
active tobacco use in 42 patients (49%). Cardiac, renal, and
cerebral comorbidities were present in 50 (58%), 21 (24%),
and seven (8%) patients respectively.
Typical chronic postprandial abdominal pain was present
in 73 patients (85%), weight loss in 66 patients (77%), food
fear with meal splitting in 54 (63%) and diarrhoea, nausea
or vomiting in 48 patients (56%). Mean weight loss was
13.6 kg (median 10.0, interquartile range [IQR] 7.0e12.5).
Malnutrition was present in 50 patients (58%), with asso-
ciated hypoalbuminaemia and body mass index <19 kg/m2.
Table 2. Type of revascularization.
Total
number ¼ 86
Digestive
revascularization
alone n ¼ 77
Associated aortic
reconstruction n ¼ 9
Aorto-hepatic and
e SMA bypass
32 (37%) None
Aorto-hepatic
bypass
4 (5%) None
Aorto-SMA
bypass
27 (31%) 5 (6%)
SMA direct
reimplantation
7 (8%) None
SMA indirect
reimplantation
6 (7%) None
SMA and IMA
reimplantation
None 4 (5%)
Transaortic
endarterectomy
1 (1%) None
SMA ¼ superior mesenteric artery; IMA ¼ inferior mesenteric
artery.
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All patients had a pre-operative arteriogram. Numbers of
pathological digestive arteries were one in six patients (7%),
two in 68 patients (79%), and three in 12 patients (14%),
with a mean number of 2.14 (median 2, IQR 1e3). The CT
was involved in 72 patients (84%), SMA in 82 patients
(95%), and IMA in 28 patients (33%). Mean angiographic
score was 4.1 (median 4, IQR 3e5).
Type of revascularization
The number of treated arteries was one in 49 patients
(57%), and two in 37 patients (43%), with a mean number
of 1.43 (MED 1/IQR 1e2).
Revascularization was complete in 46 cases (53%), and
anterograde in 79 cases (92%). Comparison of pre-operative
characteristics of patients who underwent complete revas-
cularization and patients who underwent incomplete
revascularization showed no difference (Table 1).
All revascularizations are described in Table 2. In nine
cases (10%), an associated aortic reconstruction was done
simultaneously: two aorto-aortic bypasses, one aorto-bi-
iliac bypass, and six aorto-bifemoral bypasses. All bypasses
were done using polyethylene terephthalate grafts.
Anterograde revascularizations were 31 aorta to proper
hepatic and SMA bypass (36%), an aorto-hepatic bypass in
four cases (5%), an aorto-SMA bypass in 26 cases (30%), a
SMA re-implantation in 13 cases (15%), a SMA and IMA re-
implantation in four cases (5%), and a transaortic SMA
endarterectomy in one case (1%).Table 1. Pre-operative characteristics of patients.
Total
number ¼ 86
Complete
revascularization
n ¼ 46
Incomplete
revascularization
n ¼ 40
p
Demographics data
Mean age 62 60 .98
Male gender 27 (58.7%) 25 (62.5%) .72
Cardiovascular risk factors
Diabetes 13 (28.3%) 9 (22.5%) .54
Hypertension 37 (80.4%) 35 (87.5%) .38
Dyslipidaemia 23 (50.0%) 25 (62.5%) .24
Tobacco
addiction
22 (47.8%) 20 (50.0%) .84
Comorbidities
Cardiac 28 (60.9%) 22 (55.0%) .58
Renal 11 (23.9%) 10 (25.0%) .91
Cerebral 5 (10.9%) 2 (5.0%) .32
Symptoms
Typical
abdominal
pain
38 (82.6%) 35 (87.5%) .53
Weight loss 36 (78.3%) 30 (75.0%) .72
Food fear 26 (56.5%) 28 (70.0%) .19
Digestive
troubles
28 (60.9%) 20 (50.0%) .31
Malnutrition 26 (56.5%) 24 (60.0%) .74
Mean
angiographic
score
4.2 4.0 .83Retrograde bypasses were four aorto-SMA bypasses (5%),
two aorto-SMA bypasses associated with aorto-bifemoral
bypasses (2%), and one bifurcated aorta to proper hepatic
and SMA bypass (1%). All these bypasses were retrograde
bypasses due to heavy calciﬁcations of the celiac part of the
aorta, without possibility of clamping.Thirty day mortality and morbidity
Three patients (3.5%) died during the initial post-operative
period: two from heart failure on days 3 and 5, and one
from septic shock on day 21. Post-operative morbidity was
13.9%, and consisted of one respiratory failure requiring
prolonged intubation and ventilation, two temporary acute
renal failures, one surgical site infection, three parietal he-
matomas, two acute coronary syndromes, and three graft
thromboses. Mortality and morbidity were not inﬂuenced
by the completeness of revascularization.Late results
Survival, primary patency, and secondary patency were not
inﬂuenced by the completeness of the revascularization.
Survival rate was 92.1% at 5 years and 87.9% at 10 years for
complete revascularization, and 83.2% and 76.3% respec-
tively for incomplete revascularization (Fig. 1). The primary
patency rate was 88.2% at 5 years and 84.4% at 10 years
for complete revascularization, and 88.1% at 5 and 10 years
for incomplete revascularization (Fig. 2). The secondary
patency rate was 93.6% at 5 and 10 years for complete
revascularization; and 93.7% for incomplete revasculariza-
tion (Fig. 3).
Freedom from digestive symptoms was inﬂuenced by the
completeness of the revascularization. Freedom from
digestive symptoms rate was 84.3% at 5 years and 80.3% at
10 years for complete revascularization, and 68.9% and
65.7% respectively for incomplete revascularization
(p ¼ .04) (Fig. 4).
Figure 1. Survival comparison between complete and incomplete
revascularization.
Figure 2. Primary patency comparison between complete and
incomplete revascularization.
Figure 3. Secondary patency comparison between complete and
incomplete revascularization.
Figure 4. Freedom from digestive symptoms comparison between
complete and incomplete revascularization.
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OS for CMI provides lasting long-term results, especially
when performing complete and anterograde revasculariza-
tion. It has long been known that the natural history of
patients with symptomatic chronic mesenteric ischemia is
not favourable because it carries signiﬁcant morbidity and
the risk of mortality from acute mesenteric ischemia, whichjustiﬁes mandatory revascularization.3 Open surgical pro-
cedures were ﬁrst described for CMI, but have become
proportionally much less commonly used than endovascular
procedures. In fact, since 2005, angioplasty and stenting of
the CT and the SMA have surpassed the number of open
surgical procedures, especially as endovascular techniques
have made considerable progress, including the recent use
of covered stents.9,10 The question is: Is there still a room
for OS in CMI?
A common criticism of prior studies comparing endo-
vascular versus open surgery for CMI treatment is the lack
of risk stratiﬁed analysis, because it can introduce selection
bias, given that open surgery is preferred in lower risk pa-
tients, and that endovascular surgery is preferred in higher
risk patients.7,11e15 Based on the best available evidence,
endovascular surgery has reduced early mortality and
morbidity compared with OS, but is associated with higher
rates of re-stenosis and re-intervention.8 In fact, the type of
revascularization has not been shown to affect survival, but
comparative analysis is always limited by selection bias
favouring OS for lower risk patients and endovascular
revascularization for high risk patients. Tallarita et al.8
showed by using propensity score matched comparisons
that 5 year patient survival was not inﬂuenced by the type
of revascularization (open or endovascular surgery). Thus,
given that late patient survival is not inﬂuenced by the type
of revascularization, treatment selection should be based
on factors that may affect the durability of the procedure,
such as the anatomical characteristics of the lesion. Oderich
et al.14 reported that rates of restenosis were higher among
patients treated for heavily calciﬁed or >30 mm occlusions.
However, the evidence between OS or endovascular
revascularization for CMI is still based on the preference
and experience of the individual interventionalist. Properly
designed and well executed studies are scarce. Conse-
quently, the best available level of evidence is 2b.11 A large
randomized study would be required, but is quite impos-
sible due to the low number of patients potentially suitable
for both techniques. However, based on the decreased
complication rates and rapid recovery from endovascular
revascularizations, a reasonable endovascular approach in
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which angioplasty and stent placement would not
compromise the landing site for a possible future open
bypass graft can be proposed. OS should still be the
preferred approach in patients at low risk for aortic oper-
ations who present with complex occlusive disease of their
mesenteric vessels (occlusion, long stenosis), or in patients
in whom placement of a stent would compromise subse-
quent bypass grafting.18 The purpose was not to compare
endovascular versus open surgery results, but to evaluate
the long-term results of OS, especially depending on the
completeness of the revascularization. The current study is
the ﬁrst to include a large sample of patients presenting
with CMI, with a median follow up longer than 5 years.
In the authors’ experience, OS provides long-term lasting
results, especially long-term freedom from digestive symp-
toms when performing complete revascularization. Several
studies evaluating open surgical repair for CMI have reported
symptom improvement in 90e100% of patients.12,16e21 In
the literature, initial freedom from digestive symptoms rates
following open surgical repair for CMI ranges between 65%
and 91%, but long-term freedom of digestive symptoms has
not been studied.12,16e21 However, while there is no question
about the durability of OS in chronic mesenteric ischemia,
controversy continues to surroundwhether single ormultiple
vessel revascularizations are recommended. Some authors
have already emphasized that complete revascularization is
necessary when possible: if both the CT and the SMA are
involved in the disease process, both arteries should be
reconstructed to ensure a good long term prognosis, with
lower risk of recurrence.20e23 Other authors advocate a SMA
only approach, which seem as good as multi-vessel targeting
in many aspects, and showed that symptom recurrence after
open repair only occurs when both limb of a bifurcated graft
fail or when a single graft to the SMA became stenotic.16
In the authors’ experience, complete revascularization pro-
vides positive impact on long-term freedom of digestive
symptoms.
However, OS is still associated with signiﬁcant morbidity
(5e30%) and mortality (3e12%). The initial results are
similar to those found in the literature, with acceptable
morbidity and mortality rates.12,16e21 In the authors’
experience, morbidity or mortality were not inﬂuenced by
the completeness of the revascularization. In fact, morbidity
and mortality in CMI patients are in part related to the
weight loss and malnutrition in these patients, which are
predictors of increased morbidity and mortality after major
surgery.22 This draws attention to the necessity for pre-
operative care in these fragile patients, with the use of
adequate parenteral nutrition.
However, this study has severe limitations. First, it is a
retrospective study performed at a single institution,
generating bias linked to a retrospective data collection,
even though several data were collected prospectively. The
long study period is also a severe limitation, because during
these decades there has been signiﬁcant progress in med-
ical therapy and surgical techniques that may have affected
outcomes, but the unknown or probably low incidence ofCMI makes the retrospective nature mandatory. Further-
more, the study population was selected for OS based on
ﬁtness, whereas endovascular centres present data on all
patients, ﬁt or not. This is also an important limitation of
the study.
However, the durability and efﬁcacy of open surgical
repair in CMI are convincing over time, despite high
morbidity, which justiﬁes the use of OS in CMI. Therefore,
complete surgical revascularization remains the treatment
of choice for ﬁt patients.
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